Available online 6 December 2023

Dr Blankstein has received research support from Amgen and Novartis; and is a member of the steering committee of the Lp(a)FRONTIERS CAVS study. Dr O’Gara has reported that he has no relationships relevant to the contents of this paper to disclose.

There are more references available in the full text version of this article.

© 2023 by the American College of Cardiology Foundation. Published by Elsevier.